MeriemeKlobocistaMD

Obstetrics & Gynecology • Hackensack, NJ

Gynecologic Oncology, Hospice & Palliative Medicine

Physician

Join to view full profile

Dr. Klobocista is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Klobocista's full profile

Already have an account?

Office
92 2nd St
Hackensack, NJ 07601
Phone+1 551-996-5374

Fax+1 551-996-0572

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gynecologic Oncology, 2007 - 2010
University of ConnecticutResidency, Obstetrics and Gynecology, 2003 - 2007
Northeast Ohio Medical UniversityClass of 2003

Certifications & Licensure

CA State Medical License 2007 - Present
NJ State Medical License 2015 - 2025
NY State Medical License 2010 - 2025
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Member American College of Obstetrics and Gynecology

Clinical Trials

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer Start of enrollment: 2011 Jul 08
Terminated
Not Applicable
Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery Start of enrollment: 2013 Sep 17
Terminated
Not Applicable

Publications & Presentations

PubMed

Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years
Koji Matsuo, Malcolm S. Ross, Mayu Yunokawa, Marian S. Johnson, Hiroko Machida
Surgical Oncology. 2019-06-01
12 citations
Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.
Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross, Esther Elishaev, Mayu Yunokawa
Surgical Oncology. 2018-09-01
5 citations
Clinical utility of CA-125 in the management of uterine carcinosarcoma.
Koji Matsuo, Malcolm S. Ross, Mayu Yunokawa, Marian S. Johnson, Hiroko Machida
Journal of Gynecologic Oncology. 2018-08-30

Journal Articles

Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma
Frederick R Ueland, Esther Elishaev, Tanja Pejovic, Todd B Sheridan, Terry Morgan, Joseph L Kelley, Malcolm S Ross, Stephen H Bush, Ardeshir Hakam, Lynda D Roman, Meri..., Annals of Surgical Oncology
Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma
Lynda D Roman, Terry Morgan, Joseph L Kelley, Todd B Sheridan, Stephen H Bush, Merieme M Klobocista, Miriam D Post, Malcolm S Ross, Frederick R Ueland, Ardeshir Hakam,..., Annals of Surgical Oncology